Phase-matching (w+ TM:“) devices for generation of blue light using Si [ 0] N and optically nonlinear c&x [ 4]arene layers are designed, fabricated and tested. The devices show second harmonic peak power of 17 mW at 472.9 nm and 4.5 W at 481.6 nm after IQ mm propagation length of a 1 mm broad beam using fundamental peak power of 200 W and 500 W, respectively. The strong requirements of noncriti...

Spectropholornetrie technique is used to evaluate binding of the vanadium(1U) ion to a water solublecaruc[4] arene molecule in aqueous solution. On the basis of the calculated value formation constant at25rC.we found that the eomplexation of this metal on is very favored towards 25, 26, 27, 2Stetrahydroxy-5, 11, 17, 23-tetnmulphonalic acid-calix[0]areneGaussian 03 package.

The 1, 3-bis(trimethyl silyl)ether of p-tert-butyl calix[4]arene, Rt-Bu)Ca1ixTMS21112, has beensynthesized and used as a dianionic ligand for "Sn". The complex of [(t-Bu)Ca1ixTMS2]Snexhibits exo and endo isomerism. The structural properties of [(Rp)Ca1ixTMS2]Sn, (Rpara= H,CH3, t-Bu) and the inter conversion of exoendo isomers were investigated by using of SCF-MOPM3 method.

Reaction of Zn(C6F5)2·toluene (two equivalents) with 1,3-dipropoxy-p-tert-butyl-calix[4]arene (L(1)H2) led to the isolation of the complex [{Zn(C6F5)}2L(1)] (1), whilst similar use of Zn(Me)2 resulted in the known complex [{Zn(Me)}2L(1)] (2). Treatment of L(1)H2 with in situ prepared Zn{N(SiMe3)2}2 in refluxing toluene led to the isolation of the compound [(Na)ZnN(SiMe3)2L(1)] (3). The stepwise...

The formation constants (log K), of the complexes formed between a number of amino acids(glycine , L-valine and L-alanine) with p-sulfonatocalix [4] arene at varying temperatures (25± 0.1to 65 ± 0.1 °C) in aqueous solutions and at natural pH of p-sulphonato-calix [4] arene (pH=3.2) bymeans of UV-Vis spectrophotometeric technique have been investigated. At this pH the guestmolecule is in its cat...

Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in-vitro anti-myotonic activity of the chalice-shaped cluster of mexiletine...